Viatris Inc (NASDAQ:VTRS)
| 13.94 Delayed Data As of Mar 05 |  +0.32 / +2.35%Today’s Change | 12.75 Today|||52-Week Range 19.24 | -25.61% Year-to-Date |
Latest VTRS News | Press Releases
| Where Will Pfizer Be in 1 Year? Mar 02 / MotleyFool.com - Paid Partner Content | Why Has Pfizer Stock Floundered? Feb 23 / MotleyFool.com - Paid Partner Content |
| 3 Reasons to Buy Pfizer and 1 Reason to Sell Feb 28 / MotleyFool.com - Paid Partner Content | 2 Best Pharma Stocks to Buy Right Now Feb 23 / MotleyFool.com - Paid Partner Content |
| Theravance (TBPH) Q4 Earnings Top Estimates, Revenues In Line Feb 24 / Zacks.com - Paid Partner Content | Why Viatris Stock Plunged Today Feb 22 / MotleyFool.com - Paid Partner Content |
| Viatris (VTRS) Declines on Lackluster Outlook, Announces Dividend Feb 23 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 13.59 |
| Today’s open | 13.69 |
| Day’s range | 13.36 - 13.99 |
| Volume | 13,295,277 |
| Average volume (3 months) | 13,302,524 |
| Market cap | $16.8B |
Data as of 3:59pm ET, 03/05/2021
Growth & Valuation
| Earnings growth (last year) | -3,518.10% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +3.83% |
| P/E ratio | NM |
| Price/Sales | 0.94 |
| Price/Book | 0.73 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALNYAlnylam Pharmaceutic... | +6.02 | +4.38% |
| INCYIncyte Corp | +2.76 | +3.56% |
| CTLTCatalent Inc | -0.01 | -0.01% |
| HZNPHorizon Therapeutics... | +2.46 | +2.85% |
Data as of 4:00pm ET, 03/05/2021
Financials
| Last reporting date | March 8, 2021 |
| EPS forecast (this quarter) | $1.24 |
| Annual revenue (last year) | $11.9B |
| Annual profit (last year) | -$669.9M |
| Net profit margin | -5.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Canonsburg, Pennsylvania |
Forecasts
